SIP
ABMD

Stoneridge Investment Partners’s Abiomed Inc ABMD Stock Holding History

Stoneridge Investment Partners’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-6,860
Closed -$1.17M – 151
2019
Q4 		$1.17M Sell
6,860
-6,175
-47% -$1.14M 0.4% 80
2019
Q3 		$2.32M Buy
+13,035
New +$2.82M 0.85% 43

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Stoneridge Investment Partners's ABMD Position: Q1 2020 in Review

Stoneridge Investment Partners sold out of Abiomed Inc (ABMD) in Q1 2020, closing a stake of 6,860 shares — an estimated $1.17M sold.

Stoneridge Investment Partners first reported a position in ABMD in Q3 2019 and held it in 2 quarters. The position peaked at $2.32M in Q3 2019. 412 funds tracked by Wall St. Rank hold ABMD as of Q1 2020.

  • Stoneridge Investment Partners reported no remaining Abiomed Inc position as of Q1 2020 after selling out during the quarter.
  • Stoneridge Investment Partners sold 6,860 Abiomed Inc shares in Q1 2020, an estimated $1.17M.
  • Stoneridge Investment Partners first reported a position in Abiomed Inc in Q3 2019 and held it in 2 quarters.
  • Stoneridge Investment Partners's Abiomed Inc position peaked at $2.32M in Q3 2019.
  • 412 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2020.

Based on Stoneridge Investment Partners's 13F filing for Q1 2020, filed 5 May 2020.